Semaglutide is a prescription medication originally developed to treat Type 2 diabetes and is also widely used off-label for weight management. It mimics the hormone GLP-1 (glucagon-like peptide-1), which helps regulate blood sugar levels, appetite, and digestion. By slowing gastric emptying and increasing feelings of fullness, Semaglutide helps reduce caloric intake, making it easier to lose weight.
Semaglutide is injected weekly and is combined with a reduced-calorie diet and exercise for weight management, particularly for those with obesity or related conditions like high blood pressure.
Semaglutide is typically injected once a week. The dosage starts low and gradually increases to minimize side effects, following your healthcare provider's guidelines.
The dosage for oral Semaglutide, marketed under the brand name Rybelsus, typically starts at 3 mg once daily. After 30 days, the dosage may be increased to 7 mg once daily, and then potentially to 14 mg if further blood sugar control or weight loss is needed. The medication should be taken at least 30 minutes before the first meal of the day with a small amount of water.
However, dosages may vary based on individual health needs, so it's essential to consult with a healthcare provider for personalized advice.
Common side effects include nausea, vomiting, diarrhea, and abdominal pain, which usually improve over time. More severe side effects, like pancreatitis, are rare but should be discussed with your healthcare provider.
Individual weight loss results can vary due to a range of factors, but on average, TeleDoc Meds clients typically achieve a weight loss of approximately 5% of their initial body weight. Over a 12-week period, this figure can increase to as much as 15%. For instance, someone weighing 200 pounds may expect to lose between 10-20 pounds. It's important to recognize that each person's journey is unique, and sustained success often involves making lifestyle and dietary adjustments.
Healthy weight loss is generally considered to be around 1-2 pounds per week, as rapid weight loss is not advisable from a medical standpoint.
In general, most clients typically receive their medication within 5-8 business days from their initial consultation with their provider.
Please refer to the instructional video here on how to perform a subcutaneous injection. If you encounter any difficulties or have questions, always consult your provider or a licensed medical professional for assistance.
For GLP-1 programs, patients must be at least 18 years old and no older than 75. For weight management programs, patients must be at least 18 years old and no older than 70.
Semaglutide is generally not recommended during pregnancy or breastfeeding due to insufficient safety data. Speak with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.